Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to...Weekly Roundup
New CBD (cannabidiol) products are cramming store shelves in the US as the market explodes for what many Americans believe to be a miracle cure-all.
Health24 reports...Neurology
People suffering from a debilitating and often discounted disease known as chronic fatigue syndrome may soon have something they’ve been seeking for decades:...
May 1st, 2019The authors of influential US guidelines for opioid prescriptions for chronic pain say that doctors and others in the health care system had wrongly implemented their...
April 28th, 2019Big Tobacco is increasingly using social media to find new ways to hook young people on smoking, circumventing decades of laws restricting the marketing of traditional...
United States Senate Majority Leader Mitch McConnell announced that he will introduce national legislation to raise the minimum age for people buying tobacco products...Weekly Roundup
The US Food and Drug Administration has approved Merck & Co Inc’s cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with...Weekly Roundup
AbbVie Inc has announced that the US Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis...International
The US Food and Drug Administration has halted all US sales of surgical mesh products. Boston Scientific and Coloplast were the last two companies selling the medical...Talking Points
Delegates from governments and civil society organisations, attending a global forum on fair pricing and access to medicines, have called for greater transparency around...
